State of the heart: Building science to improve women's cardiovascular health

American Journal of Critical Care

Volumn 15, Issue 6, 2006, Pages 556-566

  Rosenfeld, Anne G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DIAGNOSTIC ERROR; FEMALE; HEALTH CARE DELIVERY; HUMAN; PRACTICE GUIDELINE; RESEARCH SUBJECT; REVIEW; RISK FACTOR; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; DIAGNOSTIC ERRORS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; PRACTICE GUIDELINES; RESEARCH SUBJECTS; RISK FACTORS; WOMEN'S HEALTH;

EID: 37249055859     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2006.15.6.556     Document Type: Article

References (111)

1. Mikhail GW. Coronary heart disease in women. BMJ. 2005;331:467-468.
2. Legato MJ. Beyond women's health: the new discipline of gender-specific medicine. Med Clin North Am. 2003;87:917-937.
3. Office of Research on Women's Health. Inclusion of women in clinical research. Available at: http://orwh.od.nih.gov/inclusion/inclintro.html. Accessed July 28, 2006.
4. Grady D, Chaput L, Kristof M. Results of Systematic Review of Research on Diagnosis and Treatment of Coronary Heart Disease in Women: Evidence Report/Technology Assessment No. 80. Rockville, Md: Agency for Healthcare Research and Quality; May 2003.
5. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286:708-713.
6. Heiat A, Gross CP, Krumholz HL. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162:1682-1688.
7. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2000;343:475-480.
8. Mosca L, Ferris AF, Fabunmi R, Robertson RM. Tracking women's awareness of heart disease: an American Heart Association national study. Circulation. 2004;109:573-579.
9. Go red for women 2005 consumer survey results [press release]. Dallas, Tex: American Heart Association; February 1, 2005.
10. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update. Dallas, Tex: American Heart Association; 2005.
11. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353:671-682.
12. Lansky AJ, Hochman JS, Ward PA, et al. Percutaneous coronary interventions and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation. 2005;111:940-953.
13. Vaccarino V, Lin ZQ, Kasl SV, et al. Sex differences in health status after coronary artery bypass surgery. Circulation. 2003;108:2642-2647.
14. Jha AK, Varosy PD, Kanaya AM, et al. Differences in medical care and disease outcomes among black and white women with heart disease. Circulation. 2003;108:1089-1094.
15. Anand SS, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46:1845-1851.
16. Redberg RF. Gender, race, and cardiac care: why the differences? J Am Coll Cardiol. 2005;46:1852-1854.
17. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111:682-696.
18. Wenger NK, Lewis SJ, Welty FK, Herrington DM, Bittner V. Effect of 80 mg versus 10 mg of atorvastatin in women and men with stable coronary heart disease [abstract]. Circulation. 2005;112:II-819.
19. Bhargava R, Sandhu G, Armstrong M, Nasiri H, Sah A, Levin E. Gender bias in the use of lipid-lowering therapy [abstract]. Circulation. 2005;112:II-817.
20. Galvao M; ADHERE Scientific Advisory Committee (SAC) Investigators, Coordinators, and Study Group. Reshaping our perception of the typical hospitalized heart failure patient: a gender analysis of data from the ADHERE Heart Failure Registry. J Cardiovasc Nurs. 2005;20:442-450.
21. Daly C, Clemens F, Lopez Sendon JL, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113:490-498.
22. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143:659-672.
23. Toobert DJ, Glasgow RE, Radcliffe JL. Physiologic and related behavioral outcomes from the Women's Lifestyle Heart Trial. Ann Behav Med. 2000;22:1-9.
24. Allen JK, Scott LB, Stewart KJ, Young DR. Disparities in women's referral to and enrollment in outpatient cardiac rehabilitation. J Gen Intern Med. 2004;19:747-753.
25. Sanderson BK, Bittner V. Women in cardiac rehabilitation: outcomes and identifying risk for dropout. Am Heart J. 2005;150:1052-1058.
26. Wizemann TM, Pardue M-L. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: National Academies Press; 2001.
27. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. N Engl J Med. 1999;341:217-225.
28. Bittner V. Perspectives on dyslipidemia and coronary heart disease in women. J Am Coll Cardiol. 2005;46:1628-1635.
29. Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study, part II: gender differences in presentation, diagnosis, and outcome with regard to genderbased pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 suppl):S21-S29.
30. Merz CN, Kelsey SF, Pepine CJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology, and feasibility report. J Am Coll Cardiol. 1999;33:1453-1461.
31. Quyyumi AA. Women and ischemic heart disease: pathophysiologic implications from the Women's Ischemia Syndrome Evaluation (WISE) study and future research steps. J Am Coll Cardiol. 2006;47(3 suppl):S66-S71.
32. Pepine CJ, Kerensky RA, Lambert CR, et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006;47(3 suppl):S30-S35.
33. Redberg RF. Gender differences in acute management: invasive vs conservative approach. Paper presented at: Annual Meeting of the American Heart Association; November 12, 2005; Dallas, Tex.
34. Bransford TL, Ofili E. The paradox of coronary heart disease in African- American women. J Natl Med Assoc. 2000;92:327-333.
35. Arber S, McKinlay J, Adams A, Marceau L, Link C, O'Donnell A. Patient characteristics and inequalities in doctors' diagnostic and management strategies relating to CHD: a video-simulation experiment. Soc Sci Med. 2005;62:103-115.
36. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340:618-626.
37. Malenka D. Confusion in revascularization: are women different and why? Paper presented at: Annual Meeting of the American Heart Association; November 12, 2005; Dallas, Tex.
38. Saha S, Stettin GD, Redberg RF. Gender and willingness to undergo invasive cardiac procedures. J Gen Intern Med. 1999;14:122-125.
39. Satcher D, Fryer GE Jr, McCann J, Troutman A, Woolf SH, Rust G. What if we were equal? A comparison of the black-white mortality gap in 1960 and 2000. Health Aff (Millwood). 2005;24:459-464.
40. Banks AD, Malone RE. Accustomed to enduring: experiences of African- American women seeking care for cardiac symptoms. Heart Lung. 2005;34:13-21.
41. Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBIsponsored Women's Ischemia Syndrome Evaluation (WISE) study, part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 suppl):S4-S20.
42. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693.
43. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499-510.
44. Perry CK, Rosenfeld AG, Bennett JA, Potempa K. Heart-to-Heart: promotes exercise in rural women [abstract]. Circulation. 2005;112:II-372.
45. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22.
46. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med. 2000;343:530-538.
47. Brody JE. Fine print sends clear message: stay the course. New York Times. March 14, 2006;Science Times. Available at: http://www.nytimes.com/2006/03/14/health/14brod.html?ex=1154836800&en=999d78acd02ac138&ei=5070. Accessed August 4, 2006.
48. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative randomized controlled dietary modification trial. JAMA. 2006;295:655-666.
49. Anderson CAM, Appel LJ. Dietary modification and CVD prevention: a matter of fat [editorial]. JAMA. 2006;295:693-695.
50. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses' Health Study. Am J Epidemiol. 2005;161:672-679.
51. Brehm BJ, Seeley RJ, Daniels SR, D'Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003;88:1617-1623.
52. Parikh P, McDaniel MC, Ashen MD, et al. Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol. 2005;45:1379-1387.
53. Li TY, Rana JS, Manson JE, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006;113:499-506.
54. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Available at: http://www.cdc.gov/diabetes/pubs/factsheet05.htm. Accessed June 30, 2006.
55. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases; 1995:429-448. Publication 95-1468.
56. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-1297.
57. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA. 1991;265:627-631.
58. Becker A, Bos G, DeVegt F, et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior heart disease. Eur Heart J. 2003;24:1406-1413.
59. Brandenburg SL, Lindenfeld J, Reusch JEB, Regensteiner JG. Cardiovascular risk in women with type 2 diabetes. Med Clin North Am. 2003;87:955-969.
60. Mak KH, Haffner SM. Diabetes abolishes the gender gap in coronary heart disease. Eur Heart J. 2003;24:1385-1386.
61. Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685-696.
62. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293-1304.
63. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006;295:306-313.
64. Hodis HN, Mack WJ, Azen SP, et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med. 2003;349:535-545.
65. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613.
66. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523-534.
67. Waters DD, Alderman EL, Hsia J, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002; 288:2432-2440.
68. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 2000;343:522-529.
69. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt). 2006;15:35-44.
70. Mikkola TS, Clarkson TB. Coronary heart disease and postmenopausal hormone therapy: conundrum explained by timing [editorial]? J Womens Health (Larchmt). 2006;15:51-53.
71. Ades PA, Waldmann ML, Polk DM, Coflesky JT. Referral patterns and exercise response in the rehabilitation of female coronary patients aged greater than or equal to 62 years. Am J Cardiol. 1992;69:1422-1425.
72. Hart PL. Women's perceptions of coronary heart disease: an integrative review. J Cardiovasc Nurs. 2005;20:170-176.
73. D'Alonzo KT, Stevenson JS, Davis SE. Outcomes of a program to enhance exercise self-efficacy and improve fitness in black and Hispanic collegeage women. Res Nurs Health. 2004;27:357-369.
74. Sternfeld B, Wang H, Quesenberry CP Jr, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol. 2004;160:912-922.
75. Wilbur J, Vassalo A, Chandler P, McDevitt J, Miller AM. Midlife women's adherence to home-based walking during maintenance. Nurs Res. 2005;54:33-40.
76. Rosenfeld AG. Treatment-seeking delay among women with acute myocardial infarction: decision trajectories and their predictors. Nurs Res. 2004;53:225-236.
77. Rosenfeld AG, Lindauer A, Darney BG. Understanding treatment-seeking delay in women with acute myocardial infarction: descriptions of decision trajectories. Am J Crit Care. 2005;14:285-293.
78. DeVon HA, Zerwic JJ. The symptoms of unstable angina: do women and men differ? Nurs Res. 2003;52:108-118.
79. Knopp RH, Aikawa K. Estrogen, female gender, and heart disease. In: Topol EJ, Califf RM, Isner J, et al, eds. Textbook of Cardiovascular Medicine. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:171-188.
80. McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ. Women's early warning symptoms of acute myocardial infarction. Circulation. 2003;108:2619-2623.
81. Meischke H, Kuniyuki A, Yasui Y, Bowen DJ, Andersen R, Urban N. Information women receive about heart attacks and how it affects their knowledge, beliefs, and intentions to act in cardiac emergency. Health Care Women Int. 2002;23:149-162.
82. McSweeney JC, O'Sullivan P, Cody M, Lefler LL. Black women's symptoms of coronary heart disease [abstract]. Circulation. 2005;112:II-391.
83. Lefler LL, Bondy KN. Women's delay in seeking treatment with myocardial infarction: a meta-synthesis. J Cardiovasc Nurs. 2004;19:251-268.
84. Mak KH, Topol EJ. Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J Am Coll Cardiol. 2000;35:563-568.
85. Zerwic JJ, Ryan CJ, DeVon HA, Drell MJ. Treatment seeking for acute myocardial infarction symptoms: differences in delay across sex and race. Nurs Res. 2003;52:159-167.
86. Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med. 1995;40:379-392.
87. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283:3223-3229.
88. Murphy SA, Chen C, Cannon CP, Antman EM, Gibson CM. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction. Am J Cardiol. 2002;90:766-770.
89. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223-1225.
90. Gibler WB, Armstrong PW, Ohman EM, et al. Persistence of delays in presentation and treatment for patients with acute myocardial infarction: the GUSTO-I and GUSTO-III experience. Ann Emerg Med. 2002;39:123-130.
91. Sheifer SE, Rathore SS, Gersh BJ, et al. Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation. 2000;102:1651-1656.
92. Sweitzer NK, Douglas PS. Cardiovascular disease in women. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia, Pa: WB Saunders Co; 2005:1951-1964.
93. Riedinger MS, Dracup KA, Brecht M-L. Quality of life in women with heart failure, normative groups, and patients with other chronic conditions. Am J Crit Care. 2002;11:211-219.
94. Sundstrom J, Vasan RS. Heart failure with normal systolic function. In: Dec GW, ed. Heart Failure: A Comprehensive Guide to Diagnosis and Treatment. New York, NY: Marcel Dekker; 2005:157-180.
95. Friedman MM, King KB. Correlates of fatigue in older women with heart failure. Heart Lung. 1995;24:512-518.
96. Friedman MM. Gender differences in the health related quality of life of older adults with heart failure. Heart Lung. 2003;32:320-327.
97. Ekman I, Ehrenberg A. Fatigue in chronic heart failure: does gender make a difference? Eur J Cardiovasc Nurs. 2002;1:82-87.
98. Stephen S. Correlates of Fatigue in Older Adults With Chronic Heart Failure [doctoral dissertation]. Salt Lake City, Utah: University of Utah; 2000.
99. Dunbar SB, Jenkins LS, Hawthorne M, Porter LS. Mood disturbance in patients with recurrent ventricular dysrhythmia before insertion of implantable cardioverter defibrillator. Heart Lung. 1996;25:253-261.
100. Baker DW, Brown J, Chan KS, Dracup KA, Keeler EB. A telephone survey to measure communication, education, self-management, and health status for patients with heart failure: the Improving Chronic Illness Care Evaluation (ICICE). J Card Fail. 2005;11:36-42.
101. Haykowsky MJ, Ezekowitz JA, Armstrong PW. Therapeutic exercise for individuals with heart failure: special attention to older women with heart failure. J Card Fail. 2004;10:165-173.
102. Pepine CJ, Balaban RS, Bonow RO, et al. Women's Ischemic Syndrome Evaluation: current status and future research directions. Report of the National Heart, Lung and Blood Institute workshop, October 2-4, 2002, section 1: diagnosis of stable ischemia and ischemic heart disease. Circulation. 2004;109:e44-e46.
103. McSweeney JC. Predicting CHD events in black and white women. NIH/NINR 5R01NR004908-05. Available at: http://crisp.cit.nih.gov/crisp/CRISP_LIB.getdoc?textkey=6866889&p_grant_num=2R01NR004908-04A1&p_query=&ticket=23565650&p_audit_session_id=114989901&p_keywords= Accessed August 4, 2006.
104. Rosenfeld AG, Perrin NA, Darney BG. Symptom clusters in women with acute myocardial infarction [abstract]. Circulation. 2005;111:e56.
105. Ryan CJ, DeVon HA, Horne R, et al. Symptom clusters as an influence in delay in seeking treatment [abstract]. Circulation. 2005;112:II-391.
106. Riegel B, Moser DK, Powell M, Rector T, Havranek EP. Nonpharmacological clinical management practices among heart failure experts [abstract]. Circulation. 2005;112:II-528.
107. Jacobs AK. Women, ischemic heart disease, revascularization, and the gender gap: what are we missing? J Am Coll Cardiol. 2006;47(3 suppl):S63-S65.
108. King KB, Gerich J, Guzick DS, Queenan RA, Utter King K. Gestational diabetes and cardiovascular risk [abstract]. Circulation. 2005;112:II-521.
109. Juarbe TC. Risk factors for cardiovascular disease in Latina women. Prog Cardiovasc Nurs. Spring 1998;13:17-27.
110. Lurie N, Fremont A, Jain AK, et al. Racial and ethnic disparities in care: the perspectives of cardiologists. Circulation. 2005;111:1264-1269.
111. Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation. 2005;111:1703-1712.